TY - JOUR
T1 - Additive Manufacturing and Printing Approaches for the Development of Pharmaceutical Dosage Forms with Improved Biopharmaceutical Attributes
AU - Kawish, Syed M.
AU - Sharma, Shwetakshi
AU - Almalki, Waleed H.
AU - Alghamdi, Saad
AU - Afzal, Obaid
AU - Kazmi, Imran
AU - Altamimi, Abdulmalik S.A.
AU - Al-Abbasi, Fahad A.
AU - Beg, Sarwar
AU - Ahmad, Farhan J.
N1 - Publisher Copyright:
© 2022 Bentham Science Publishers.
PY - 2022
Y1 - 2022
N2 - The pharmaceutical industry is moving towards the future and is witnessing innovation in drug development through the introduction of personalized medicine technologies. Instead of adapting the dose thata patient needs, they were adapted to the manufacturer’s dose. Nowpatient-specific or customized dosing methods and dosing combinations have superior persistence to the standard mass-produced drugs. Printing technology has gained interest during the last few years to manufacture personalized dosage forms. For manufacturing personalized drug products, three-dimensional printing (3DP) has expanded to the pharmaceutical industry. With the approval of the first 3DP product, an unprecedented opportunity for discovering new compounds and technologies has arisen. This article has re-evaluated various printing technology and theirutilization in personalized medicines. Further, we also discussed its history, advantages, challenges and differenttypes of printing technologies with advantages and limitations, particularly in the area of pharmaceutical research.
AB - The pharmaceutical industry is moving towards the future and is witnessing innovation in drug development through the introduction of personalized medicine technologies. Instead of adapting the dose thata patient needs, they were adapted to the manufacturer’s dose. Nowpatient-specific or customized dosing methods and dosing combinations have superior persistence to the standard mass-produced drugs. Printing technology has gained interest during the last few years to manufacture personalized dosage forms. For manufacturing personalized drug products, three-dimensional printing (3DP) has expanded to the pharmaceutical industry. With the approval of the first 3DP product, an unprecedented opportunity for discovering new compounds and technologies has arisen. This article has re-evaluated various printing technology and theirutilization in personalized medicines. Further, we also discussed its history, advantages, challenges and differenttypes of printing technologies with advantages and limitations, particularly in the area of pharmaceutical research.
KW - 3D printing
KW - Additive manufacturing
KW - computer aided software
KW - inkjet based printing
KW - laser-based printing
KW - nozzle based printing
KW - personalized medicines
UR - http://www.scopus.com/inward/record.url?scp=85143644609&partnerID=8YFLogxK
U2 - 10.2174/1389200223666220616123842
DO - 10.2174/1389200223666220616123842
M3 - Review article
C2 - 35713126
AN - SCOPUS:85143644609
SN - 1389-2002
VL - 23
SP - 616
EP - 629
JO - Current Drug Metabolism
JF - Current Drug Metabolism
IS - 8
ER -